Skip to main content

Table 1 Univariate analysis of correlation between phosphorylation of transgelin-2 at S145 residue and clinicopathologocial factors

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variables Total (n) p-S145-transgelin-2 level p value
  Positive n(%) Negative n(%)  
Sex
 Male 69 39(64) 30(57) 0.544
 Female 45 22(36) 23(43)  
Age at Surgery (years)
  < 65 66 38(62) 28(53) 0.406
  ≥ 65 48 23(38) 25(47)  
Tumour Differentiation
 Well/Moderate 79 38(62) 41(77) 0.125
 Poor 35 23(38) 12(23)  
Tumor Stage
 I-II 53 22(36) 31(58) 0.027
 III-IV 61 39(64) 22(42)  
Tumor location
 Head 87 48(79) 39(74) 0.676
 Others 27 13(21) 14(26)  
Tumor Size
  < 2 cm 36 13(21) 23(43) 0.020
  ≥ 2 cm 78 48(79) 30(57)  
Metastasis status
 Patients with metastasis 2 2(3) 0(0) 0.539
 Patients without metastasis 112 59(97) 53(100)  
Lymph Node Involvement
 Positve 58 37(61) 21(40) 0.040
 Negative 56 24(39) 32(60)  
Vascular invastion
 Positve 72 40(66) 32(60) 0.705
 Negative 42 21(34) 21(40)